Figure 2
Figure 2. Effect of rituximab infusion on the frequencies of CD79a+ B cells in tissues. Panels A through F demonstrate the rituximab effect on LN CD79a+ B cells in a RM with complete B-cell depletion in tissues (A-C) versus a RM with incomplete B-cell depletion in tissues (D-F). LNs were collected before (day −7 pi; A,D) at 28 days pi (B,E) and at day 300 pi (C,F). Panels G through R demonstrate the rituximab effect on intestinal CD79a+ B cells from both lamina propria (LP; G-L) and Peyer patches (PP; M-R). Slides were examined with a Leica DMLB microscope (Leica Microsystems, Wetzlar, Germany) using the following objective lenses and numeric apertures: N PLAN 5×/0.12 (panels A-F); N PLAN 10×/0.25 (panels M-R); and N PLAN 20×/0.4 (panels G-L). Images were acquired with Spot Insight color 3.2.0 software (Diagnostic Instruments, Sterling Heights, MI) and processed with Adobe Photoshop Elements version 3.0 (Adobe Systems, San Jose, CA).

Effect of rituximab infusion on the frequencies of CD79a+ B cells in tissues. Panels A through F demonstrate the rituximab effect on LN CD79a+ B cells in a RM with complete B-cell depletion in tissues (A-C) versus a RM with incomplete B-cell depletion in tissues (D-F). LNs were collected before (day −7 pi; A,D) at 28 days pi (B,E) and at day 300 pi (C,F). Panels G through R demonstrate the rituximab effect on intestinal CD79a+ B cells from both lamina propria (LP; G-L) and Peyer patches (PP; M-R). Slides were examined with a Leica DMLB microscope (Leica Microsystems, Wetzlar, Germany) using the following objective lenses and numeric apertures: N PLAN 5×/0.12 (panels A-F); N PLAN 10×/0.25 (panels M-R); and N PLAN 20×/0.4 (panels G-L). Images were acquired with Spot Insight color 3.2.0 software (Diagnostic Instruments, Sterling Heights, MI) and processed with Adobe Photoshop Elements version 3.0 (Adobe Systems, San Jose, CA).

Close Modal

or Create an Account

Close Modal
Close Modal